|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2010-7-5
|
|
pubmed:abstractText |
Studies have associated thiazolidinedione (TZD) treatment with cardiovascular disease (CVD) and questioned whether the two available TZDs, rosiglitazone and pioglitazone, have different CVD risks. We compared CVD incidence, cardiovascular (CV), and all-cause mortality in type 2 diabetic patients treated with rosiglitazone or pioglitazone as their only TZD.
|
|
pubmed:grant |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
1099-1557
|
|
pubmed:author |
pubmed-author:BilikDoriD,
pubmed-author:BrownMorton BMB,
pubmed-author:CrossonJesse CJC,
pubmed-author:HermanWilliam HWH,
pubmed-author:HsiaoVictoria CVC,
pubmed-author:KarterAndrew JAJ,
pubmed-author:LasserNorman LNL,
pubmed-author:MangioneCarol MCM,
pubmed-author:MarreroDavid GDG,
pubmed-author:McEwenLaura NLN,
pubmed-author:SelbyJoe VJV,
pubmed-author:TsengChien-WenCW
|
|
pubmed:copyrightInfo |
(c) 2010 John Wiley & Sons, Ltd.
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
19
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
715-21
|
|
pubmed:dateRevised |
2011-6-8
|
|
pubmed:meshHeading |
pubmed-meshheading:20583206-Aged,
pubmed-meshheading:20583206-Cardiovascular Diseases,
pubmed-meshheading:20583206-Diabetes Mellitus, Type 2,
pubmed-meshheading:20583206-Female,
pubmed-meshheading:20583206-Humans,
pubmed-meshheading:20583206-Hypoglycemic Agents,
pubmed-meshheading:20583206-Male,
pubmed-meshheading:20583206-Managed Care Programs,
pubmed-meshheading:20583206-Middle Aged,
pubmed-meshheading:20583206-Proportional Hazards Models,
pubmed-meshheading:20583206-Prospective Studies,
pubmed-meshheading:20583206-Risk Factors,
pubmed-meshheading:20583206-Thiazolidinediones
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
Thiazolidinediones, cardiovascular disease and cardiovascular mortality: translating research into action for diabetes (TRIAD).
|
|
pubmed:affiliation |
Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
|
|
pubmed:publicationType |
Journal Article,
Comparative Study,
Research Support, U.S. Gov't, P.H.S.,
Research Support, N.I.H., Extramural
|
